share_log

GlaxoSmithKline | 20-F: FY2022 Annual Report

SEC ·  Mar 11, 2023 00:13
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.